In 15% of patients with multiple myeloma (MM), a hematological disease characterized by the accumulation of malignant plasma cells in the bone marrow, cyclin D1 is aberrantly expressed as a result of the t(11;14)(q13;q32) translocation in [14]. Here, CCND1 is linked to AL amyloidosis.